Juno Therapeutics (NASDAQ: JUNO) resumed trading down 40% after the company announced that it has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Trader Talk Trading Halts

Juno Therapeutics (JUNO) PT Lowered to $34 at Maxim GroupNovember 23, 2016 1:51 PM Juno Therapeutics (JUNO) to Resume Trading at 8:30AM ET after Clinical Hold AnnouncedNovember 23, 2016 8:05 AM Kite Pharma (KITE) on Watch as Juno Trial Placed on Clinical HoldNovember 23, 2016 8:02 AM Juno Therapeutics (JUNO) Halted for News ReleaseNovember 23, 2016 8:01 AM Juno Therapeutics (JUNO) JCAR015 Phase II ROCKET Trial Placed on Clinical HoldNovember 23, 2016 8:01 AM Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical HoldNovember 23, 2016 8:00 AM